While the exact mechanism HDAC inhibition employs to induce cell cycle arrest and apoptosis of ovarian cancer cells remains elusive, much preclinical data supports that HDAC inhibition synergizes with many cytotoxic chemotherapies including paclitaxel, carboplatin and docetaxel [25, 47, 54–57]. The gene discussed is HDAC9; the disease is ovarian carcinoma.